September 28, 2015 — New 12-month clinical trial outcomes assessing the safety and performance of the Boston Scientific ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
September 25, 2015 – The Icahn School of Medicine at Mount Sinai has launched the international TWILIGHT clinical trial ...
September 23, 2015 — CeloNova BioSciences Inc. announced that it has received conditional approval to start an ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
September 22, 2015 — Hansen Medical Inc. announced it will exhibit its Magellan robotic system at the Cardiovascular and ...
September 18, 2015 — For the first time, European Society of Cardiology (ESC) guidelines give the highest degree of ...
September 15, 2015 — AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved Brilinta ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
September 14, 2015 — Healthcare providers can assess a patient’s risk of sudden cardiac death (SCD) following a ...
September 11, 2015 — New Haven Pharmaceuticals Inc. announced U.S. Food and Drug Administration (FDA) approval of ...
September, 11, 2015 – Japanese medical vendor Nipro Corp. signed a definitive agreement to acquire Infraredx Inc., maker ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
Two key requirements for today’s cardiovascular information systems (CVIS) are solid integrations with both enterprise ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
September 9, 2015 — St. Jude Medical Inc. announced that five-year results from the FAME trial have confirmed the long ...
September 8, 2015 — In a new study reported in The Journal of Thoracic and Cardiovascular Surgery, researchers found a ...
September 8, 2015 — Extending clot-preventing dual antiplatelet therapy (DAPT) beyond the recommended 12 months after ...